R&D | May 02, 2026
Thermo Fisher opens flagship US Bioprocess Design Center in Massachusetts
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
The Cambridge hub is designed to expand Zealand Pharma’s global research capabilities
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Dr. Quirk said the program’s mechanism offers a targeted approach to disrupted brain signaling in compulsivity-related disorders
The conference highlighted research suggesting that deuterium levels may influence key biological processes
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
